Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-06-28 @ 12:12 AM
Study NCT ID:
NCT06946160
Status:
COMPLETED
Last Update Posted:
2025-05-07
First Post:
2025-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines
Sponsor:
Espad Pharmed
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BOT.ESP.AF.III.02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None